The National Medicines Regulatory Authority (NMRA) has announced plans to reduce the prices of 90 types of medicines.
According to a senior NMRA official, ongoing legal proceedings in district courts have posed challenges for several pharmaceutical companies. However, the authority is taking steps to resolve these issues promptly.
Once these obstacles are addressed, the NMRA has assured that the price reductions will be implemented without delay, providing relief to consumers.
